The University of Texas - Houston Stroke Team

Clinical Research Stroke Studies

Argatroban In Acute Stroke: ARTTS study
P.I.: Andrew D. Barreto, M.D.
Combination: IV-tPA and Argatroban
Stem Cell Therapy for Ischemic Stroke
P.I.: Sean I. Savitz, M.D.
Safety study of patient's own bone-marrow derived stem cells
SHRINC—Pioglitazone for Intracerebral Hemorrhage
P.I.: Nicole R. Gonzales, M.D.
Novel treatment for intracerebral hemorrhage
CLOTBUST-HF
P.I.: Andrew D. Barreto, M.D.
Study tests the safety of a novel operator-independent 2-MHz ultrasound delivery system
TEG Stroke Study
P.I.: James C. Grotta, M.D.
Hematological study for both ischemic and hemorrhagic strokes utilizing thromboelastogram (TEG) blood tests
DIAS-4
Site P.I.: Sean I. Savitz, M.D.
Efficacy study of intravenous thrombolytic Desmoteplase in 3-9 hour ischemic stroke patients
  ALIAS
Site P.I.: Elizabeth Jones, M.D. (Emergency Medicine program)
Efficacy study of high-dose Albumin for acute ischemic stroke
MR-Rescue
UT site P.I.: James C. Grotta, M.D.
Mechanical Embolectomy for Ischemic Stroke
Interventional Management of Stroke–3 (IMS-3)
UT site P.I.: James C. Grotta, M.D.
Intra-arterial thrombolysis versus intravenous
RESPECT
PFO closure versus medical management
UT site P.I.: Richard Smalling, M.D. (Cardiovascular Medicine)
CREST
Site P.I.: Nicole R. Gonzales, M.D.
Efficacy study for carotid stenosis: endarterectomy vs. stenting